Sleep and non-motor symptoms in Parkinson's disease

Journal of Neural Transmission

Volumn 120, Issue 4, 2013, Pages 565-569

  Maass, Antonia ^a   Reichmann, Heinz ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Non motor symptoms; Parkinson's disease; Quality of life; Sleep disorders

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

AKINESIA; ANTIDEPRESSANT ACTIVITY; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; HUMAN; INSOMNIA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESS LEGS SYNDROME; SLEEP DISORDER;

DEPRESSIVE DISORDER; HUMANS; PARKINSON DISEASE; QUALITY OF LIFE; SLEEP DISORDERS;

EID: 84875722200     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-0966-4     Document Type: Conference Paper

References (43)

1. Aurora RN, Zak RS, Maganti RK, Auerbach SH, Casey KR, Chowdhuri S, Karippot A et al (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6(1):85-95
2. Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, Zappia M, Musch B, Depression/Parkinson Italian Study Group (2006) Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. J Neurol 253(5):601-607 (Pubitemid 43876990)
3. Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 24(11):1641-1649
4. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D (2010) Pramipexole for the treatment of depressive symptoms in patients with parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9(6):573-580
5. Chaudhuri KR, Naidu Y (2008) Early Parkinson's disease and non-motor issues. J Neurol 255(Suppl 5):33-38
6. Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464-474
7. Chaudhuri KR, Yates L, Martinez-Martin P (2005) The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5(4):275-283 (Pubitemid 41149661)
8. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 21(7):916-923 (Pubitemid 44184590)
9. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A et al (2010) The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25(6):704-709
10. Dhawan V, Healy DG, Pal S, Chaudhuri KR (2006) Sleep-related problems of Parkinson's disease. Age Ageing 35(3):220-228
11. Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64(3):327-337 (Pubitemid 46376789)
12. Fantini ML, Gagnon JF, Filipini D, Montplaisir J (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10):1418-1420 (Pubitemid 37463382)
13. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52(9):1908-1910 (Pubitemid 29260911)
14. Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Hogl B, Benes H et al (2012) European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 19(11):1385-1396
15. Giladi N, Fichtner A, Poewe W, Boroojerdi B (2010) Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease. J Neural Transm 117(12):1395-1399
16. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2006) Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 67(5):853-858 (Pubitemid 44394202)
17. Global Parkinson's Disease Survey Steering Committee (2002) Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 17(1):60-67 (Pubitemid 36041261)
18. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 22(6):839-842 (Pubitemid 46800106)
19. Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K et al (2009) Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24(10):1468-1474
20. Korczyn AD (2006) Management of sleep problems in Parkinson's disease. J Neurol Sci 248(1-2):163-166 (Pubitemid 44647296)
21. Kumru H, Iranzo A, Carrasco E, Valldeoriola F, Marti MJ, Santamaria J, Tolosa E (2008) Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep 31(10):1418-1421
22. Kunz D, Mahlberg R (2010) A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 19(4):591-596
23. Lee MA, Prentice WM, Hildreth AJ, Walker RW (2007) Measuring symptom load in idiopathic Parkinson's disease. Parkinsonism Relat Disord 13(5):284-289 (Pubitemid 47002328)
24. Leeman AL, O'Neill CJ, Nicholson PW, Deshmukh AA, Denham MJ, Royston JP, Dobbs RJ, Dobbs SM (1987) Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 24(5):637-643 (Pubitemid 18078359)
25. Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11(6):512-519 (Pubitemid 19006460)
26. Lemke MR, Brecht HM, Koester J, Reichmann H (2006) Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. J Neurol Sci 248(1-2):266-270 (Pubitemid 44754866)
27. Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG et al (2007) Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22(11):1623-1629 (Pubitemid 47477925)
28. Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS (2011) Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord 17(2):89-94
29. Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL, EASE-PD Adjunct Study Investigators (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68(14):1108-1115 (Pubitemid 46559844)
30. Poewe WH, Rascol O, Quinn N, Tolosa E, Oertel WH, Martignoni E, Rupp M, Boroojerdi B, SP 515 Investigators (2007) Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 6(6):513-520 (Pubitemid 46734759)
31. Politis M, Wu K, Molloy S, Bain PG, Chaudhuri KR, Piccini P (2010) Parkinson's disease symptoms: the patient's perspective. Mov Disord 25(11):1646-1651
32. Rektorova I, Rektor I, Bares M, Dostal V, Ehler E, Fanfrdlova Z, Fiedler J et al (2003) Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol 10(4):399-406 (Pubitemid 41754760)
33. Romigi A, Stanzione P, Marciani MG, Izzi F, Placidi F, Cervellino A, Giacomini P, Brusa L, Grossi K, Pierantozzi M (2006) Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study. J Neural Transm 113(12):1909-1913 (Pubitemid 44749632)
34. Rye DB, Jankovic J (2002) Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58(3):341-346 (Pubitemid 34150904)
35. Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69(3):308-312 (Pubitemid 30636233)
36. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson's Disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19(10):1196-1202 (Pubitemid 39429962)
37. Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S (1998) Sleep disorders in Parkinson's disease. J Neurol 245(Suppl 1):S15-S18
38. Trenkwalder C (1998) Sleep dysfunction in Parkinson's disease. Clin Neurosci 5(2):107-114
39. Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P et al (2011a) Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26(1):90-99
40. Trenkwalder C, Kohnen R, Hogl B, Metta V, Sixel-Doring F, Frauscher B, Hulsmann J, Martinez-Martin P, Chaudhuri KR (2011b) Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord 26(4):644-652
41. Van den Kerchove M, Jacquy J, Gonce M, De Deyn PP (1993) Sustained-release levodopa in parkinsonian patients with nocturnal disabilities. Acta Neurol Belg 93(1):32-39 (Pubitemid 23089926)
42. Wolters ECh, Braak H (2006) Parkinson's disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309-319 (Pubitemid 44622216)
43. Ziemssen T, Reichmann H (2007) Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat Disord 13(6):323-332 (Pubitemid 47212791)